Table 1. Baseline characteristics.

Characteristic	BMS1	BMS2	SES	p Value
Cases	7	6	10
Age (years)	61.0 (10.49)	64.2 (7.78)	58.3 (9.82)	0.50
Time post-stenting (months)	7.29 (2.06)	44.50 (24.56)	8.60 (2.72)	<0.0001*
Male sex	6	6	8	0.51
Stent diameter (mm)	3.03 (0.34)	3.04 (0.25)	3.05 (0.28)	0.99
Stent length (mm)	18.75 (3.77)	17.50 (3.99)	22.00 (6.03)	0.15
Hypertension	5	6	8	0.38
Diabetes mellitus	1	2	6	0.16
Smoking	3	5	6	0.33
CHO (mmol/l)	4.33 (0.88)	4.03 (0.36)	4.51 (1.13)	0.50
TG (mmol/l)	1.37 (0.52)	2.08 (1.03)	2.00 (1.53)	0.77
HDL (mmol/l)	0.91 (0.43)	1.04 (0.09)	1.03 (0.22)	0.80
LDL (mmol/l)	2.81 (0.69)	2.35 (0.22)	2.88 (0.97)	0.39
OCT target vessel
LAD	4	4	9	0.24
LCX	1	0	3
RCA	2	2	0

BMS1 group, bare-metal stent with 5–10 months follow-up; BMS2 group, bare-metal stent with 23–93 months follow-up; SES group, sirloimus-eluting stent with 6–12 months of follow-up; cholesterol (CHO); triglyceride (TG); high-density lipoprotein cholesterol (HDL); low-density lipoprotein cholesterol (LDL); OCT, optical coherence tomography; left anterior descending artery (LAD); left circumflex artery (LCX); right coronary artery (RCA).*Within three groups, p<0.0001; BMS1 vs SES, p = NS.